Tianda Pharmaceuticals Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG887471038
HKD
0.10
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lee's Pharmaceutical Holdings Ltd.
Pak Fah Yeow International Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Antengene Corp. Ltd.
Clover Biopharmaceuticals Ltd.
China Biotech Services Holdings Ltd.
CANbridge Pharmaceuticals Inc.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Lansen Pharmaceutical Holdings Ltd.
Fusen Pharmaceutical Co., Ltd.
Tianda Pharmaceuticals Ltd.

Why is Tianda Pharmaceuticals Ltd. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Tianda Pharmaceuticals Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Tianda Pharmaceuticals Ltd.
-42.26%
-0.75
79.07%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-10.04%
EBIT Growth (5y)
-230.42%
EBIT to Interest (avg)
-10.17
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.62
Tax Ratio
13.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.78%
ROE (avg)
0.33%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.74
EV to EBIT
-7.73
EV to EBITDA
-26.93
EV to Capital Employed
0.76
EV to Sales
1.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.85%
ROE (Latest)
-12.00%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-9What is not working for the Company
OPERATING PROFIT(Q)

Lowest at HKD -14.38 MM

PRE-TAX PROFIT(Q)

Lowest at HKD -33.71 MM

NET PROFIT(Q)

Lowest at HKD -33.02 MM

RAW MATERIAL COST(Y)

Grown by 19.36% (YoY

NET SALES(Q)

Lowest at HKD 136.63 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -10.52 %

Here's what is not working for Tianda Pharmaceuticals Ltd.

Operating Profit
Lowest at HKD -14.38 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (HKD MM)

Pre-Tax Profit
Lowest at HKD -33.71 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (HKD MM)

Net Profit
Lowest at HKD -33.02 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (HKD MM)

Net Sales
Lowest at HKD 136.63 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Operating Profit Margin
Lowest at -10.52 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost
Grown by 19.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales